ID SRCN1_MOUSE Reviewed; 1250 AA. AC Q9QWI6; O70298; DT 16-FEB-2004, integrated into UniProtKB/Swiss-Prot. DT 16-JAN-2004, sequence version 2. DT 04-NOV-2026, entry version 167. DE RecName: Full=SRC kinase signaling inhibitor 1; DE AltName: Full=SNAP-25-interacting protein; DE Short=SNIP; DE AltName: Full=p130Cas-associated protein; DE AltName: Full=p140Cap; GN Name=Srcin1; Synonyms=Kiaa1684, P140; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090 {ECO:0000312|EMBL:AAC15635.1}; RN [1] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). RA Croci L., Bossolasco M., Consalez G.G.; RL Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases. RN [2] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 271-1250 (ISOFORM 3). RC TISSUE=Brain {ECO:0000312|EMBL:BAC98232.1}; RX PubMed=14621295; DOI=10.1093/dnares/10.4.167; RA Okazaki N., Kikuno R., Ohara R., Inamoto S., Koseki H., Hiraoka S., RA Saga Y., Nagase T., Ohara O., Koga H.; RT "Prediction of the coding sequences of mouse homologues of KIAA gene: III. RT The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs RT identified by screening of terminal sequences of cDNA clones randomly RT sampled from size-fractionated libraries."; RL DNA Res. 10:167-180(2003). RN [3] {ECO:0000305} RP ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY. RX PubMed=14657239; DOI=10.1091/mbc.e03-09-0689; RA Di Stefano P., Cabodi S., Erba E.B., Margaria V., Bergatto E., RA Giuffrida M.G., Silengo L., Tarone G., Turco E., Defilippi P.; RT "p130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated RT protein involved in cell spreading."; RL Mol. Biol. Cell 15:787-800(2004). RN [4] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Embryonic brain; RX PubMed=15345747; DOI=10.1074/mcp.m400085-mcp200; RA Ballif B.A., Villen J., Beausoleil S.A., Schwartz D., Gygi S.P.; RT "Phosphoproteomic analysis of the developing mouse brain."; RL Mol. Cell. Proteomics 3:1093-1101(2004). RN [5] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-411; SER-588; SER-1054 AND RP SER-1110, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200; RA Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.; RT "Comprehensive identification of phosphorylation sites in postsynaptic RT density preparations."; RL Mol. Cell. Proteomics 5:914-922(2006). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain cortex; RX PubMed=17114649; DOI=10.1074/mcp.m600046-mcp200; RA Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F., RA Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B., RA Panse C., Schlapbach R., Mansuy I.M.; RT "Qualitative and quantitative analyses of protein phosphorylation in naive RT and stimulated mouse synaptosomal preparations."; RL Mol. Cell. Proteomics 6:283-293(2007). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-309 AND TYR-464, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=18034455; DOI=10.1021/pr0701254; RA Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; RT "Large-scale identification and evolution indexing of tyrosine RT phosphorylation sites from murine brain."; RL J. Proteome Res. 7:311-318(2008). RN [8] RP TISSUE SPECIFICITY. RX PubMed=19146815; DOI=10.1016/j.neuron.2008.11.013; RA Jaworski J., Kapitein L.C., Gouveia S.M., Dortland B.R., Wulf P.S., RA Grigoriev I., Camera P., Spangler S.A., Di Stefano P., Demmers J., RA Krugers H., Defilippi P., Akhmanova A., Hoogenraad C.C.; RT "Dynamic microtubules regulate dendritic spine morphology and synaptic RT plasticity."; RL Neuron 61:85-100(2009). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47; SER-52; SER-79; SER-87; RP SER-98; SER-211; SER-247; SER-293; TYR-309; SER-366; SER-375; SER-392; RP SER-430; SER-432; SER-559; SER-562; SER-566; SER-569; SER-579; SER-581; RP SER-583; SER-588; SER-664; SER-688; THR-691; THR-704; SER-911; SER-933; RP SER-1054; SER-1110 AND SER-1127, AND IDENTIFICATION BY MASS SPECTROMETRY RP [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, Brown adipose tissue, and Kidney; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [10] RP METHYLATION [LARGE SCALE ANALYSIS] AT ARG-397; ARG-404 AND ARG-567, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain; RX PubMed=24129315; DOI=10.1074/mcp.o113.027870; RA Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M., RA Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V., RA Bedford M.T., Comb M.J.; RT "Immunoaffinity enrichment and mass spectrometry analysis of protein RT methylation."; RL Mol. Cell. Proteomics 13:372-387(2014). CC -!- FUNCTION: Acts as a negative regulator of SRC by activating CSK which CC inhibits SRC activity and downstream signaling, leading to impaired CC cell spreading and migration. Regulates dendritic spine morphology. CC Involved in calcium-dependent exocytosis. May play a role in CC neurotransmitter release or synapse maintenance (By similarity). CC {ECO:0000250}. CC -!- SUBUNIT: Interacts with the N-terminal coiled-coil region of SNAP25. CC Interacts with BCAR1/p130Cas and SRC through its C-terminal domain. CC Interacts with CSK, CTTN, SORBS3/vinexin, SYP and MAPRE3/EB3 (By CC similarity). {ECO:0000250}. CC -!- INTERACTION: CC Q9QWI6; Q61140: Bcar1; NbExp=2; IntAct=EBI-775592, EBI-77088; CC Q9QWI6; P56945: BCAR1; Xeno; NbExp=3; IntAct=EBI-775592, EBI-702093; CC Q9QWI6-2; Q14247: CTTN; Xeno; NbExp=2; IntAct=EBI-775607, EBI-351886; CC Q9QWI6-2; Q9UPY8: MAPRE3; Xeno; NbExp=5; IntAct=EBI-775607, EBI-726739; CC Q9QWI6-2; O60504-2: SORBS3; Xeno; NbExp=4; IntAct=EBI-775607, EBI-1222956; CC Q9QWI6-2; P00523: SRC; Xeno; NbExp=2; IntAct=EBI-775607, EBI-848039; CC Q9QWI6-2; P07825: Syp; Xeno; NbExp=2; IntAct=EBI-775607, EBI-976085; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9QXY2}. CC Cytoplasm, cytoskeleton {ECO:0000250|UniProtKB:Q9QXY2}. Cell CC projection, axon {ECO:0000250|UniProtKB:Q9QXY2}. Cell projection, CC dendrite {ECO:0000250|UniProtKB:Q9QXY2}. Presynapse CC {ECO:0000250|UniProtKB:Q9QXY2}. Postsynapse CC {ECO:0000250|UniProtKB:Q9QXY2}. Postsynaptic density CC {ECO:0000250|UniProtKB:Q9QXY2}. Note=Localized to the perinuclear CC region, lamellopodia, cortical actin and actin stress fibers but not to CC focal adhesions. Strongly expressed in axons and dendrites of the CA1 CC and CA3 hippocampal regions and of the dentate gyrus. Detected in both CC presynapses and postsynapses and enriched in postsynaptic density CC fractions. {ECO:0000250|UniProtKB:Q9QXY2}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1 {ECO:0000269|PubMed:14657239}; Synonyms=1a CC {ECO:0000303|PubMed:14657239}; CC IsoId=Q9QWI6-1; Sequence=Displayed; CC Name=2 {ECO:0000269|PubMed:14657239}; Synonyms=1b CC {ECO:0000303|PubMed:14657239}; CC IsoId=Q9QWI6-2; Sequence=VSP_050631; CC Name=3 {ECO:0000305}; CC IsoId=Q9QWI6-3; Sequence=VSP_050632; CC -!- TISSUE SPECIFICITY: Expressed predominantly in central nervous system CC with high levels detected in cortex, cerebellum, midbrain and spinal CC cord (at protein level). Also expressed in testis and epithelial-rich CC tissues such as mammary gland, lung and kidney. CC {ECO:0000269|PubMed:14657239, ECO:0000269|PubMed:19146815}. CC -!- PTM: Tyrosine-phosphorylated in response to EGF and to cell adhesion to CC integrin ligands. {ECO:0000250|UniProtKB:Q9C0H9}. CC -!- SIMILARITY: Belongs to the SRCIN1 family. {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=BAC98232.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF040944; AAC15635.1; -; mRNA. DR EMBL; U59873; AAD00087.1; -; mRNA. DR EMBL; AK129422; BAC98232.1; ALT_FRAME; mRNA. DR PIR; T34101; T34101. DR RefSeq; NP_061361.2; NM_018873.2. DR AlphaFoldDB; Q9QWI6; -. DR BioGRID; 207768; 21. DR FunCoup; Q9QWI6; 518. DR IntAct; Q9QWI6; 371. DR STRING; 10090.ENSMUSP00000103222; -. DR GlyCosmos; Q9QWI6; 12 sites, 1 glycan. DR GlyGen; Q9QWI6; 13 sites, 1 O-linked glycan (11 sites). DR iPTMnet; Q9QWI6; -. DR PhosphoSitePlus; Q9QWI6; -. DR SwissPalm; Q9QWI6; -. DR PaxDb; 10090-ENSMUSP00000103222; -. DR PeptideAtlas; Q9QWI6; -. DR ProteomicsDB; 263337; -. [Q9QWI6-1] DR ProteomicsDB; 263338; -. [Q9QWI6-2] DR ProteomicsDB; 263339; -. [Q9QWI6-3] DR DNASU; 56013; -. DR GeneID; 56013; -. DR KEGG; mmu:56013; -. DR AGR; MGI:1933179; -. DR CTD; 80725; -. DR MGI; MGI:1933179; Srcin1. DR eggNOG; ENOG502QPNH; Eukaryota. DR InParanoid; Q9QWI6; -. DR PhylomeDB; Q9QWI6; -. DR BioGRID-ORCS; 56013; 0 hits in 78 CRISPR screens. DR CD-CODE; CE726F99; Postsynaptic density. DR PRO; PR:Q9QWI6; -. DR Proteomes; UP000000589; Unplaced. DR RNAct; Q9QWI6; protein. DR GO; GO:0015629; C:actin cytoskeleton; ISO:GO_Central. DR GO; GO:0030424; C:axon; ISS:UniProtKB. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0030425; C:dendrite; ISS:UniProtKB. DR GO; GO:0030175; C:filopodium; ISO:GO_Central. DR GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO. DR GO; GO:0030027; C:lamellipodium; ISO:GO_Central. DR GO; GO:0098984; C:neuron to neuron synapse; ISO:GO_Central. DR GO; GO:0043025; C:neuronal cell body; ISO:GO_Central. DR GO; GO:0098794; C:postsynapse; ISS:UniProtKB. DR GO; GO:0014069; C:postsynaptic density; IDA:MGI. DR GO; GO:0098793; C:presynapse; IDA:SynGO. DR GO; GO:0045202; C:synapse; ISS:UniProtKB. DR GO; GO:0019904; F:protein domain specific binding; ISO:GO_Central. DR GO; GO:0019901; F:protein kinase binding; ISS:UniProtKB. DR GO; GO:1990708; P:conditioned place preference; ISO:GO_Central. DR GO; GO:0007162; P:negative regulation of cell adhesion; IDA:MGI. DR GO; GO:0050709; P:negative regulation of protein secretion; ISO:GO_Central. DR GO; GO:0061099; P:negative regulation of protein tyrosine kinase activity; ISS:UniProtKB. DR GO; GO:0061003; P:positive regulation of dendritic spine morphogenesis; ISO:GO_Central. DR GO; GO:0061098; P:positive regulation of protein tyrosine kinase activity; ISS:UniProtKB. DR GO; GO:0098974; P:postsynaptic actin cytoskeleton organization; ISO:GO_Central. DR GO; GO:0030334; P:regulation of cell migration; ISS:UniProtKB. DR GO; GO:0061001; P:regulation of dendritic spine morphogenesis; ISS:UniProtKB. DR GO; GO:0051963; P:regulation of synapse assembly; IDA:SynGO. DR GO; GO:0034446; P:substrate adhesion-dependent cell spreading; ISS:UniProtKB. DR FunFam; 1.20.58.1540:FF:000001; SRC kinase signaling inhibitor 1; 1. DR Gene3D; 1.20.58.1540; Actin interacting protein 3, C-terminal domain; 1. DR InterPro; IPR022782; AIP3-like_C. DR InterPro; IPR051825; SRCIN1. DR PANTHER; PTHR22741; P140CAP/SNIP-RELATED; 1. DR PANTHER; PTHR22741:SF5; SRC KINASE SIGNALING INHIBITOR 1; 1. DR Pfam; PF03915; AIP3; 1. PE 1: Evidence at protein level; KW Alternative splicing; Cell projection; Coiled coil; Cytoplasm; KW Cytoskeleton; Exocytosis; Methylation; Phosphoprotein; Reference proteome; KW Synapse. FT CHAIN 1..1250 FT /note="SRC kinase signaling inhibitor 1" FT /id="PRO_0000072012" FT REGION 19..78 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 352..448 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 538..710 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 714..764 FT /note="Interaction with SNAP25" FT /evidence="ECO:0000250|UniProtKB:Q9QXY2" FT REGION 924..982 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1016..1094 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 1155..1250 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COILED 712..753 FT /evidence="ECO:0000255" FT COILED 793..813 FT /evidence="ECO:0000255" FT COMPBIAS 19..45 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 65..75 FT /note="Gly residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 354..364 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 365..374 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 381..399 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 437..448 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 552..563 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 590..607 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 628..640 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 701..710 FT /note="Low complexity" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1069..1078 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1217..1250 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 47 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 52 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 79 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 86 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q9C0H9" FT MOD_RES 87 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 98 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 211 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 233 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9QXY2" FT MOD_RES 237 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9QXY2" FT MOD_RES 247 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 293 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 309 FT /note="Phosphotyrosine" FT /evidence="ECO:0007744|PubMed:18034455, FT ECO:0007744|PubMed:21183079" FT MOD_RES 366 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 375 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 392 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 397 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0007744|PubMed:24129315" FT MOD_RES 404 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0007744|PubMed:24129315" FT MOD_RES 411 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16452087" FT MOD_RES 430 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 432 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 464 FT /note="Phosphotyrosine" FT /evidence="ECO:0007744|PubMed:18034455" FT MOD_RES 559 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 562 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 566 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 567 FT /note="Omega-N-methylarginine" FT /evidence="ECO:0007744|PubMed:24129315" FT MOD_RES 569 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 579 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 581 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 583 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 588 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16452087, FT ECO:0007744|PubMed:21183079" FT MOD_RES 664 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 688 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 691 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 704 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 911 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 933 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 951 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q9C0H9" FT MOD_RES 1054 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16452087, FT ECO:0007744|PubMed:21183079" FT MOD_RES 1110 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:16452087, FT ECO:0007744|PubMed:21183079" FT MOD_RES 1127 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT VAR_SEQ 1..41 FT /note="MQPWQCLRRFALAWWERTAEGRARSPREEVGPRDPGGRGEP -> MGNAPSQ FT (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14657239, ECO:0000303|Ref.1" FT /id="VSP_050631" FT VAR_SEQ 1207..1250 FT /note="Missing (in isoform 3)" FT /evidence="ECO:0000303|PubMed:14621295" FT /id="VSP_050632" FT CONFLICT 740..741 FT /note="NV -> KL (in Ref. 2; BAC98232)" FT /evidence="ECO:0000305" FT CONFLICT 755 FT /note="P -> R (in Ref. 2; BAC98232)" FT /evidence="ECO:0000305" FT CONFLICT 759..760 FT /note="DV -> EL (in Ref. 2; BAC98232)" FT /evidence="ECO:0000305" FT CONFLICT 821 FT /note="M -> V (in Ref. 2; BAC98232)" FT /evidence="ECO:0000305" FT CONFLICT 960 FT /note="C -> G (in Ref. 2; BAC98232)" FT /evidence="ECO:0000305" FT CONFLICT 1121..1122 FT /note="KL -> NV (in Ref. 1; AAD00087)" FT /evidence="ECO:0000305" SQ SEQUENCE 1250 AA; 134859 MW; 85F394C9523F78C0 CRC64; MQPWQCLRRF ALAWWERTAE GRARSPREEV GPRDPGGRGE PDPERSSPPM LSADDAEYPR EYRTLGGGGG GGSGGRRFSN VGLVHTSERR HTVIAAQSLE ALSGLQKADA DRKRDAFMDH LKSKYPQHAL ALRGQQDRMR EQVGGWTVDP VCLLSSLCSH LHGDSTPSGA GQPAQQPNYW SFKTRSSRHT QGAQPGLADQ AAKLSYASAE SLETMSEAEL PLGFSRMNRF RQSLPLSRSA SQTKLRSPGV LFLQFGEETR RVHITHEVSS LDTLHALIAH MFPQKLTMGM LKSPNTAILI KDEARNVFYE LEDVRDIQDR SIIKIYRKEP LYAAFPGSHL TNGDLRREMV YASRESSPTR RLNNLSPASH LASSSPPPGL PSGLPSGLPS GSPSRSRLSY AGGRPPSYAG SPVHHAAERL GGAPTGQGVS PSPSAILERR DVKPDEDLAG KAGGMVLVKG EGLYADPYGL LHEGRLSLAA AAETHSHTRA RAACTSGVPC ALSAPTPLPR CSPTWRTRCT RRALAALYGD GYGFRLPPSS PQKLADVSAP SGGPPPPHSP YSGPPSRGSP VRQSFRKDSG SSSVFAESPG GKARSTGSAS TAGAPPSELF PGPGERSLVG FGPPVPAKDT ETRERMEAME KQIASLTGLV QSALLRGSEP ETPSEKVEGS NGAATPSAPV CGSGSKSSGA TPVSGPPPPS ASSTPAGQPT AVSRLQMQLH LRGLQNSASD LRGQLQQLRN VQLQNQESVR ALLKPTEADV SMRVSEAARR QEDPLQRQRT LVEEERLRYL NDEELITQQL NDLEKSVEKI QRDVAHNHRL MPGPELEEKA LVLKQLGETL TELKAHFPGL QSKMRVVLRV EVEAVKFLKE EPQRLDGLLK RCRGVTDTLA QIRRQVDEGM WPPPNNLLNQ SPKKVAAETD FSKGLDFEIP PPSPPLNLHE LSGPAEGTPL TPKSTNPTKC LDASSKRNTD KAVSVEAAER DWEEKRAALT QYSAKDINRL LEETQAELLK AIPDLDCASK THPGPAPTPD HKPPKAPHGQ KAAPRTEPSG RRGSDELTVP RYRTEKPSKS PPPPPPRRSF PSSHGLTTTR TGEVVVTSKK DSVFIKKAES EELEVQKPQV KLRRAVSEVV RPASTPPIMA SAIKDEDDEE RIIAELESGG SSVPPMKVVT PGASRLKAAQ GPAGSPDKGK HGKQRTEYMR IQAQQQATKP SKEVSGPNET SSPGSEKPSG SRTSIPVLTS FGARNSSISF //